{
    "zip": "02142",
    "sector": "Healthcare",
    "fullTimeEmployees": 1453,
    "longBusinessSummary": "Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing RNA interference (RNAi) therapeutics. The company's pipeline of investigational RNAi therapeutics focus on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria (AHP); and OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1 (PH1). In addition, the company is developing givosiran for the treatment of adolescent patients with AHP; lumasiran for the treatment of advanced PH1 and recurrent renal stones; patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; and vutrisiran for the treatment of ATTR amyloidosis. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Sanofi Genzyme to discover, develop, and commercialize RNAi therapeutics. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.",
    "city": "Cambridge",
    "phone": "617 551 8200",
    "state": "MA",
    "country": "United States",
    "companyOfficers": [],
    "website": "https://www.alnylam.com",
    "maxAge": 1,
    "address1": "675 West Kendall Street",
    "fax": "617 551 8101",
    "industry": "Biotechnology",
    "address2": "Henri A. Termeer Square",
    "ebitdaMargins": -0.88311994,
    "profitMargins": -1.11823,
    "grossMargins": 0.83251,
    "operatingCashflow": -614696000,
    "revenueGrowth": 0.491,
    "operatingMargins": -0.94528,
    "ebitda": -661734976,
    "targetLowPrice": 108,
    "recommendationKey": "buy",
    "grossProfits": 414801000,
    "freeCashflow": 136807120,
    "targetMedianPrice": 209,
    "currentPrice": 148.13,
    "earningsGrowth": null,
    "currentRatio": 4.381,
    "returnOnAssets": -0.1306,
    "numberOfAnalystOpinions": 20,
    "targetMeanPrice": 209.55,
    "debtToEquity": 100.602,
    "returnOnEquity": -0.85027003,
    "targetHighPrice": 275,
    "totalCash": 2327865088,
    "totalDebt": 760441024,
    "totalRevenue": 749313984,
    "totalCashPerShare": 19.464,
    "financialCurrency": "USD",
    "revenuePerShare": 6.373,
    "quickRatio": 4.043,
    "recommendationMean": 2.1,
    "exchange": "NMS",
    "shortName": "Alnylam Pharmaceuticals, Inc.",
    "longName": "Alnylam Pharmaceuticals, Inc.",
    "exchangeTimezoneName": "America/New_York",
    "exchangeTimezoneShortName": "EST",
    "isEsgPopulated": false,
    "gmtOffSetMilliseconds": "-18000000",
    "quoteType": "EQUITY",
    "symbol": "ALNY",
    "messageBoardId": "finmb_2796659",
    "market": "us_market",
    "annualHoldingsTurnover": null,
    "enterpriseToRevenue": 21.552,
    "beta3Year": null,
    "enterpriseToEbitda": -24.404,
    "52WeekChange": -0.054268003,
    "morningStarRiskRating": null,
    "forwardEps": -3.92,
    "revenueQuarterlyGrowth": null,
    "sharesOutstanding": 119601000,
    "fundInceptionDate": null,
    "annualReportExpenseRatio": null,
    "totalAssets": null,
    "bookValue": 6.327,
    "sharesShort": 3755339,
    "sharesPercentSharesOut": 0.031400003,
    "fundFamily": null,
    "lastFiscalYearEnd": 1609372800,
    "heldPercentInstitutions": 0.94692004,
    "netIncomeToCommon": -837904000,
    "trailingEps": -7.127,
    "lastDividendValue": null,
    "SandP52WeekChange": 0.23092365,
    "priceToBook": 23.41236,
    "heldPercentInsiders": 0.00596,
    "nextFiscalYearEnd": 1672444800,
    "yield": null,
    "mostRecentQuarter": 1632960000,
    "shortRatio": 5.42,
    "sharesShortPreviousMonthDate": 1636934400,
    "floatShares": 118869218,
    "beta": 0.869234,
    "enterpriseValue": 16149098496,
    "priceHint": 2,
    "threeYearAverageReturn": null,
    "lastSplitDate": null,
    "lastSplitFactor": null,
    "legalType": null,
    "lastDividendDate": null,
    "morningStarOverallRating": null,
    "earningsQuarterlyGrowth": null,
    "priceToSalesTrailing12Months": 23.643621,
    "dateShortInterest": 1639526400,
    "pegRatio": -3.23,
    "ytdReturn": null,
    "forwardPE": -37.788265,
    "lastCapGain": null,
    "shortPercentOfFloat": 0.0365,
    "sharesShortPriorMonth": 4048537,
    "impliedSharesOutstanding": null,
    "category": null,
    "fiveYearAverageReturn": null,
    "previousClose": 151,
    "regularMarketOpen": 151,
    "twoHundredDayAverage": 172.33446,
    "trailingAnnualDividendYield": null,
    "payoutRatio": 0,
    "volume24Hr": null,
    "regularMarketDayHigh": 153.2477,
    "navPrice": null,
    "averageDailyVolume10Day": 1180990,
    "regularMarketPreviousClose": 151,
    "fiftyDayAverage": 177.1804,
    "trailingAnnualDividendRate": null,
    "open": 151,
    "toCurrency": null,
    "averageVolume10days": 1180990,
    "expireDate": null,
    "algorithm": null,
    "dividendRate": null,
    "exDividendDate": null,
    "circulatingSupply": null,
    "startDate": null,
    "regularMarketDayLow": 147.41,
    "currency": "USD",
    "regularMarketVolume": 594186,
    "lastMarket": null,
    "maxSupply": null,
    "openInterest": null,
    "marketCap": 17716496384,
    "volumeAllCurrencies": null,
    "strikePrice": null,
    "averageVolume": 774342,
    "dayLow": 147.41,
    "ask": 147.74,
    "askSize": 1200,
    "volume": 594186,
    "fiftyTwoWeekHigh": 212,
    "fromCurrency": null,
    "fiveYearAvgDividendYield": null,
    "fiftyTwoWeekLow": 125.08,
    "bid": 129.06,
    "tradeable": false,
    "dividendYield": null,
    "bidSize": 900,
    "dayHigh": 153.2477,
    "regularMarketPrice": 148.13,
    "preMarketPrice": null,
    "logo_url": "https://logo.clearbit.com/alnylam.com"
}